Journal of Hepatology
Volume 51, Issue 5 , Pages 949-959 , November 2009

A review of quality of life instruments used in liver transplantation

  • Colleen L. Jay

      Affiliations

    • Division of Organ Transplantation, Department of Surgery, Feinberg School of Medicine, Northwestern University, 750 N. Lake Shore Drive, Chicago, IL 60611, USA
    • ,
  • Zeeshan Butt

      Affiliations

    • Division of Organ Transplantation, Department of Surgery, Feinberg School of Medicine, Northwestern University, 750 N. Lake Shore Drive, Chicago, IL 60611, USA
    • Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
    • Institute for Healthcare Studies, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 312 5035519; fax: +1 312 5032777.
    • ,
  • Daniela P. Ladner

      Affiliations

    • Division of Organ Transplantation, Department of Surgery, Feinberg School of Medicine, Northwestern University, 750 N. Lake Shore Drive, Chicago, IL 60611, USA
    • ,
  • Anton I. Skaro

      Affiliations

    • Division of Organ Transplantation, Department of Surgery, Feinberg School of Medicine, Northwestern University, 750 N. Lake Shore Drive, Chicago, IL 60611, USA
    • ,
  • Michael M. Abecassis

      Affiliations

    • Division of Organ Transplantation, Department of Surgery, Feinberg School of Medicine, Northwestern University, 750 N. Lake Shore Drive, Chicago, IL 60611, USA

References 

  1. 2007 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1997–2006. Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation 2007.
  2. Constitution of World Health Organization. World Health Organization 1948.
  3. Atherton PJ, Sloan JA, Atherton PJ, Sloan JA. Rising importance of patient-reported outcomes. Lancet Oncol. 2006;7:883–884
  4. Leidy NK, Beusterien K, Sullivan E, Richner R, Muni NI. Integrating the patient’s perspective into device evaluation trials. Value Health. 2006;9:394–401
  5. Lohr KN, Aaronson NK, Alonso J, Burnam MA, Patrick DL, Perrin EB, et al. Evaluating quality-of-life and health status instruments: development of scientific review criteria. Clin Ther. 1996;18:979–992
  6. Coons SJ, Rao S, Keininger DL, Hays RD. A comparative review of generic quality-of-life instruments. Pharmacoeconomics. 2000;17:13–35
  7. Colonna JO 2nd, Brems JJ, Hiatt JR, Millis JM, Ament ME, Baldrich-Quinones WJ, et al. The quality of survival after liver transplantation. Transplant Proc. 1988;20:594–597
  8. Brazier JE, Harper R, Jones NM, O’Cathain A, Thomas KJ, Usherwood T. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305:160–164
  9. Hellgren A, Berglund B, Gunnarsson U, Hansson K, Norberg U, Bäckman L. Health-related quality of life after liver transplantation. Liver Transplant Surg. 1998;4:215–221
  10. McHorney CA, Ware JE, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994;32:40–66
  11. McHorney CA, Ware JE, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31:247–263
  12. Stewart AL, Hays RD, Ware JE. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care. 1988;26:724–735
  13. Gralnek IM, Hays RD, Kilbourne A, Rosen HR, Keeffe EB, Artinian L, et al. Development and evaluation of the Liver Disease Quality of Life instrument in persons with advanced, chronic liver disease – the LDQOL 1.0. Am J Gastroenterol. 2000;95:3552–3565
  14. Knechtle SJ, Fleming MF, Barry KL, Steen D, Pirsch JD, D’Alessandro AM, et al. Liver transplantation in alcoholics: assessment of psychological health and work activity. Transplant Proc. 1993;25:1916–1918
  15. Phillips AL, Walker EL, Martin JE, First MR, Hanto DW, Whiting JF. Quality of life as a predictor of morbidity, mortality, and resource utilization after solid-organ transplant. Transplant Proc. 2001;33:1886
  16. Goetzmann L, Klaghofer R, Wagner-Huber R, Halter J, Boehler A, Muellhaupt B, et al. Quality of life and psychosocial situation before and after a lung, liver or an allogeneic bone marrow transplant. Swiss Med Wkly. 2006;136:281–290
  17. Krasnoff JB, Vintro AQ, Ascher NL, Bass NM, Dodd MJ, Painter PL. Objective measures of health-related quality of life over 24 months post-liver transplantation. Clin Transplant. 2005;19:1–9
  18. Ratcliffe J, Longworth L, Young T, Bryan S, Burroughs A, Buxton M. Cost-effectiveness of liver transplantation team. Assessing health-related quality of life pre and post-liver transplantation: a prospective multicenter study. Liver Transpl. 2002;8:263–270
  19. Tolba RH, Wrigge B, Machein U, Minor T, Kalff JC, Hirner A, et al. Conversion to Neoral for tacrolimus-related adverse effects in liver transplant recipients and improvement in quality of life. Transplant Proc. 2001;33:3446–3447
  20. Kanwal F, Hays RD, Kilbourne AM, Dulai GS, Gralnek IM. Are physician-derived disease severity indices associated with health-related quality of life in patients with end-stage liver disease?. Am J Gastroenterol. 2004;99:1726–1732
  21. Saab S, Ibrahim AB, Shpaner A, Younossi ZM, Lee C, Durazo F, et al. MELD fails to measure quality of life in liver transplant candidates. Liver Transplant. 2005;11:218–223
  22. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–370
  23. Moorey S, Greer S, Watson M, Gorman C, Rowden L, Tunmore R, et al. The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer. Br J Psychiatry. 1991;158:255–259
  24. Upadhyaya AK, Stanley I. Hospital anxiety depression scale. Br J Gen Pract. 1993;43:349–350
  25. Aylard PR, Gooding JH, McKenna PJ, Snaith RP. A validation study of three anxiety and depression self-assessment scales. J Psychosom Res. 1987;31:261–268
  26. Forsberg A, Lorenzon U, Nilsson F, Backmana L. Pain and health related quality of life after heart, kidney, and liver transplantation. Clin Transplant. 1999;13:453–460
  27. Nickel R, Wunsch A, Egle UT, Lohse AW, Otto G. The relevance of anxiety, depression, and coping in patients after liver transplantation. Liver Transplant. 2002;8:63–71
  28. Goetzmann L, Wagner-Huber R, Klaghofer R, Muellhaupt B, Clavien PA, Buddeberg C, et al. Waiting for a liver transplant: psychosocial well-being, spirituality, and need for counselling. Transplant Proc. 2006;38:2931–2936
  29. Goetzmann L, Klaghofer R, Wagner-Huber R, Halter J, Boehler A, Muellhaupt B, et al. Psychosocial vulnerability predicts psychosocial outcome after an organ transplant: results of a prospective study with lung, liver, and bone-marrow patients. J Psychosom Res. 2007;62:93–100
  30. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–571
  31. Metcalfe M, Goldman E. Validation of an inventory for measuring depression. Br J Psychiatry. 1965;111:240–242
  32. Singh N, Gayowski T, Wagener MM, Marino IR. Depression in patients with cirrhosis. Impact on outcome. Dig Dis Sci. 1997;42:1421–1427
  33. Santos Junior R, Miyazaki MC, Domingos NA, Valério NI, Silva RF, Silva RC. Patients undergoing liver transplantation: psychosocial characteristics, depressive symptoms, and quality of life. Transplant Proc. 2008;40:802–804
  34. Riether AM, Smith SL, Lewison BJ, Cotsonis GA, Epstein CM. Quality-of-life changes and psychiatric and neurocognitive outcome after heart and liver transplantation. Transplantation. 1992;54:444–450
  35. Mejı´as D, Ramı´rez P, Rı´os A, Munitiz V, Hernandez Q, Bueno F, et al. Recurrence of alcoholism and quality of life in patients with alcoholic cirrhosis following liver transplantation. Transplant Proc. 1999;31:2472–2474
  36. Anonymous . EuroQol – a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy. 1990;16:199–208
  37. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol group. Ann Med. 2001;33:337–343
  38. Brazier J, Jones N, Kind P. Testing the validity of the EuroQol and comparing it with the SF-36 health survey questionnaire. Qual Life Res. 1993;2:169–180
  39. Anderson RT, Aaronson NK, Wilkin D. Critical review of the international assessments of health-related quality of life. Qual Life Res. 1993;2:369–395
  40. Gutteling JJ, de Man RA, Busschbach JJ, Darlington AS. Overview of research on health-related quality of life in patients with chronic liver disease. Neth J Med. 2007;65:227–234
  41. Bryan S, Ratcliffe J, Neuberger JM, Burroughs AK, Gunson BK, Buxton MJ. Health-related quality of life following liver transplantation. Qual Life Res. 1998;7:115–120
  42. Ratcliffe J, Young T, Longworth L, Buxton M. An assessment of the impact of informative dropout and nonresponse in measuring health-related quality of life using the EuroQol (EQ-5D) descriptive system. Value Health. 2005;8:53–58
  43. Dobbels F, Vanhaecke J, Desmyttere A, Dupont L, Nevens F, De Geest S. Prevalence and correlates of self-reported pretransplant nonadherence with medication in heart, liver, and lung transplant candidates. Transplantation. 2005;79:1588–1595
  44. Ratcliffe J, Buxton M, Young T, Longworth L. Determining priority for liver transplantation: a comparison of cost per QALY and discrete choice experiment-generated public preferences. Appl Health Econ Health Policy. 2005;4:249–255
  45. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The sickness impact profile: development and final revision of a health status measure. Med Care. 1981;19:787–805
  46. de Bruin AF, de Witte LP, Stevens F, Diederiks JP. Sickness impact profile: the state of the art of a generic functional status measure. Soc Sci Med. 1992;35:1003–1014
  47. Tarter RE, Switala J, Arria A, Plail J, Van Thiel D. Quality of life before and after orthotopic hepatic transplantation. Arch Int Med. 1991;151:1521–1526
  48. Tarter RE, Switala J, Arria A, Van Thiel DH. Impact of liver disease on daily living in transplantation candidates. J Clin Epidemiol. 1991;44:1079–1083
  49. Holzner B, Kemmler G, Kopp M, Dachs E, Kaserbacher R, Spechtenhauser B, et al. Preoperative expectations and postoperative quality of life in liver transplant survivors. Arch Phys Med Rehabil. 2001;82:73–79
  50. Belle SH, Porayko MK. Improvement in quality of life after transplantation for recipients in the NIDDK liver transplantation database. Transplant Proc. 1995;27:1230–1232
  51. Belle SH, Porayko MK, Hoofnagle JH, Lake JR, Zetterman RK. Changes in quality of life after liver transplantation among adults. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Liver Transplantation Database (LTD). Liver Transplant Surg. 1997;3:93–104
  52. Gross CR, Malinchoc M, Kim WR, Evans RW, Wiesner RH, Petz JL, et al. Quality of life before and after liver transplantation for cholestatic liver disease. Hepatology. 1999;29:356–364
  53. Kim WR, Lindor KD, Malinchoc M, Petz JL, Jorgensen R, Dickson ER. Reliability and validity of the NIDDK-QA instrument in the assessment of quality of life in ambulatory patients with cholestatic liver disease. Hepatology. 2000;32:924–929
  54. Cowling T, Jennings LW, Goldstein RM, Sanchez EQ, Chinnakotla S, Klintmalm GB, et al. Liver transplantation and health-related quality of life: scoring differences between men and women. Liver Transplant. 2004;10:88–96
  55. Kanwal F, Spiegel BM, Hays RD, Durazo F, Han SB, Saab S, et al. Prospective validation of the short form liver disease quality of life instrument. Aliment Pharmacol Ther. 2008;28:1088–1101
  56. Younossi ZM, Guyatt G, Kiwi M, Boparai N, King D. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut. 1999;45:295–300
  57. Younossi ZM, McCormick M, Price LL, Boparai N, Farquhar L, Henderson JM, et al. Impact of liver transplantation on health-related quality of life. Liver Transplant. 2000;6:779–783
  58. Cella D, Nowinski CJ, Cella D, Nowinski CJ. Measuring quality of life in chronic illness: the functional assessment of chronic illness therapy measurement system. Arch Phys Med Rehabil. 2002;83:S10–S17
  59. Garratt A, Schmidt L, Mackintosh A, Fitzpatrick R. Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ. 2002;324:1417
  60. Tome S, Wells JT, Said A, Lucey MR. Quality of life after liver transplantation. A systematic review. J Hepatol. 2008;48:567–577
  61. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21:271–292
  62. Ara R, Brazier J. Predicting the Short Form-6D Preference-based index using the eight mean Short Form-36 health dimension scores: estimating preference-based health-related utilities when patient level data are not available. Value Health 2008 July 18 [Epub ahead of print].
  63. Günther OH, Roick C, Angermeyer MC, König HH. Responsiveness of EQ-5D utility indices in alcohol-dependent patients. Drug Alcohol Depend. 2008;92:291–295
  64. Scuffham PA, Whitty JA, Mitchell A, Viney R. The use of QALY weights for QALY calculations: a review of industry submissions requesting listing on the Australian Pharmaceutical Benefits Scheme 2002–4. Pharmacoeconomics 2008;26:297–310.
  65. Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med. 2003;349:931–940
  66. Chan EY, Olson LC, Kisthard JA, Perkins JD, Bakthavatsalam R, Halldorson JB, et al. Ischemic cholangiopathy following liver transplantation from donation after cardiac death donors. Liver Transplant. 2008;14:604–610
  67. Foley DP, Fernandez LA, Leverson G, Chin LT, Krieger N, Cooper JT, et al. Donation after cardiac death: the University of Wisconsin experience with liver transplantation. Ann Surg. 2005;242:724–731
  68. Olthoff KM, Merion RM, Ghobrial RM, Abecassis MM, Fair JH, Fisher RA, et al. Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg. 2008;242:314–323
  69. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006;6:783–790
  70. Schaubel DE, Sima CS, Goodrich NP, Feng S, Merion RM. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant. 2008;8:419–425
  71. Institute of Medicine. Cancer care for the whole patient: Meeting psychosocial health needs. Washington, DC: The National Academy Press; 2007.
  72. Sprangers MA, Aaronson NK. The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: a review. J Clin Epidemiol. 1992;45:743–760
  73. Fallowfield L, Ratcliffe D, Jenkins V, Saul J. Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer. 2001;84:1011–1015
  74. Laine C, Davidoff F, Lewis CE, Nelson EC, Nelson E, Kessler RC, et al. Important elements of outpatient care: a comparison of patients’ and physicians’ opinions. Ann Int Med. 1996;125:640–645
  75. Velikova G, Booth L, Smith AB, Brown PM, Lynch P, Brown JM, et al. Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. J Clin Oncol. 2004;22:714–724
  76. Nunnally JC, Bernstein IH. Psychometric theory. 3rd ed.. New York: McGraw-Hill; 1994;
  77. Fleiss JL. Statistical methods for rates and proportions. 2nd ed.. New York: Wiley; 1981;
  78. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–174
  79. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–483
  80. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale – a review of validation data and clinical results. J Psychosom Res. 1997;42:17–41
  81. Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol. 1997;36:551–559

☆ The authors who have taken part in this study declared that they do not have anything to disclose regarding funding from industry or conflict of interest with respect to this manuscript.

PII: S0168-8278(09)00472-3

doi: 10.1016/j.jhep.2009.07.010

Journal of Hepatology
Volume 51, Issue 5 , Pages 949-959 , November 2009

Article Tools

* Image Usage & Resolution